New Delhi: A study on the financial burden of diabetes on the common man in the country has found that 60% of diabetics

Rupali Mukherjee | TNN

New Delhi: The US Food and Drug Administration (FDA) has directed pharma biggie GlaxoSmithKline to stop enrolling new subjects worldwide for conducting safety studies of controversial diabetes pill, Rosiglitazone (Avandia) till regulators decide whether the drug will be banned.

Pramod Panwar | TNN

Palanpur: At daybreak, this 45-year-old woman in Chhaniyan village in Vadgam taluka of Banaskantha gets ready for her morning walk. And, when she leaves, she has in tow a rather strange company. Held in her hands are ropes that are pulling along a buffalo.

P.Sunderarajan

NEW DELHI : Soon, insulin-dependent diabetic patients may be able to lead a more relaxed life, without having to constantly monitor their glucose levels and frequently take insulin shots.

Mumbai, 4 JULY: President Pratibha Patil today called upon the medical community to evolve a comprehensive strategy to tackle the emerging threat of lifestyle diseases and provide health care to the rural areas.

Teena Thacker

Following a recent study by the Journal of American Medical Association (JAMA), stating that anti-diabetic drug Rosiglitazone may be associated with an increased risk of life-threatening diseases, the Drug Controller General of India (DCGI) on Friday put on hold the clinical trails of the drug going on at 10 centres in the country.

Rupali Mukherjee | TNN

Mumbai: Long-suffering diabetics can find daily insulin jabs painful and cumbersome, so a new, once-a-week shot may soon revolutionize treatment for thousands suffering from the dreaded disease.

New Delhi: Maulana Azad Medical College (MAMC) is conducting trials of a new drug